Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
HPO |
|
|
|
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Hereditary leiomyomatosis and renal cell cancer (HLRCC; OMIM 605839) is the predisposition to develop smooth muscle tumours of the skin and uterus and/or renal cancer and is associated with mutations in the fumarate hydratase gene (FH).
|
15937070 |
2006 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer (HLRCC; OMIM 605839) is the predisposition to develop smooth muscle tumours of the skin and uterus and/or renal cancer and is associated with mutations in the fumarate hydratase gene (FH).
|
15937070 |
2006 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a tumour predisposition syndrome caused by heterozygous germline mutations in the fumarate hydratase (FH) gene.
|
16155190 |
2006 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
HLRCC is caused by heterozygous germline mutations in the fumarate hydratase (fumarase) gene.
|
19373782 |
2009 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis renal cell carcinoma (HLRCC) is an aggressive form of RCC characterized by germline mutation of the Krebs cycle enzyme fumarate hydratase (FH), and one known to be highly metastatic and unusually lethal.
|
19963135 |
2010 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
|
20618355 |
2011 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is caused by mutations in the Krebs cycle enzyme fumarate hydratase (FH).
|
20978192 |
2010 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant syndrome characterized by skin piloleiomyomas, uterine leiomyomas and papillary type 2 renal cancer caused by germline mutations in the fumarate hydratase (FH) gene.
|
22086304 |
2012 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
HLRCC is caused by heterozygous germline mutations in the fumarate hydratase (FH) gene.
|
22473397 |
2012 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an aggressive form of RCC characterized by germline mutation of fumarate hydratase (FH), followed by somatic loss of the remaining wild-type allele and known to be a highly metastatic and lethal malignancy compared to other RCCs.
|
22867999 |
2012 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
HLRCC is caused by germline mutations in the fumarate hydratase (FH) gene which inactivate the enzyme and alters the function of the tricarboxylic acid (Krebs) cycle.
|
25012257 |
2014 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome secondary to germline fumarate hydratase (FH) mutation presents with cutaneous and uterine leiomyomas, and a distinctive aggressive renal carcinoma.
|
26574848 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare autosomal dominant disorder characterized by fumarate hydratase (FH) gene mutation.
|
26637880 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH).
|
26983443 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC.
|
28266706 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant manifestation of cutaneous and uterine leiomyomas together with renal cancer due to autosomal dominant germline mutations of fumarate hydratase gene.
|
29267457 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is caused by autosomal dominant germline mutations in the fumarate hydratase (FH) gene and is characterized by cutaneous leiomyomas, uterine leiomyomas and aggressive renal malignancies.
|
29423582 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a hereditary cancer syndrome characterized by inactivation of the Krebs cycle enzyme fumarate hydratase (FH).
|
29917289 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) represents an autosomal dominant syndrome that results from a germline mutation in fumarate hydratase gene (FH).
|
30171332 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Hereditary leiomyomatosis renal cell carcinoma (HLRCC) is characterized by oxidative phosphorylation (OXPHOS) deficiency caused by fumarate hydratase (FH) nullizyogosity.
|
30625329 |
2019 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma (HLRCC)/fumarate hydratase deficient renal cell carcinoma (FHRCC) is defined by molecular genetic changes (mutation/LOH in fumarate hydratase (FH) gene).
|
30785029 |
2019 |